This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kawaguchi, H. Articles by Tamura, M. Search for Related Content PubMed PubMed Citation Articles by Kawaguchi, H. Articles by Tamura, M. Pubmed/NCBI databases OMIM Compound via MeSH Substance via MeSH

Acceleration of Fracture Healing in Nonhuman Primates by Fibroblast Growth Factor-2

Department of Orthopedic Surgery, University of Tokyo Graduate School of Medicine (H.K., K.N.), Hongo 7-3-1, Bunkyo 113-8655, Tokyo; Institute for Frontier in Medical Science, Kyoto University (Y.T.), Kyoto; Faculty of Medical Engineering, Suzuka University of Medical Science (Y.I.), Mie; and Kaken Pharmaceutical Co., Ltd. (I.A., J.A., T.N., Y.H., M.T.), Minamikawara-machi, Kyoto, Japan

Address all correspondence and requests for reprints to: Hiroshi Kawaguchi, M.D., Ph.D., Department of Orthopedic Surgery, University of Tokyo Graduate School of Medicine, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail: kawaguchi-ort{at}h.u-tokyo.ac.jp

One of the greatest needs in the clinical bone field is a bioactive agent to stimulate bone formation. We previously reported that fibroblast growth factor-2 (FGF-2) exhibited strong anabolic actions on bone formation in models of rodents and dogs. Aiming at a clinical application, this study was undertaken to clarify the effect of a single local application of recombinant human FGF-2 on fracture healing in nonhuman primates. After a fracture was created at the midshaft of the right ulna of animals and stabilized with an intramedullary nail, gelatin hydrogel alone (n = 10) or gelatin hydrogel containing 200 µg FGF-2 (n = 10) was injected into the fracture site. Although 4 of 10 animals treated with the vehicle alone remained in a nonunion state even after 10 weeks, bone union was complete at 6 weeks in all 10 animals treated with FGF-2. Significant differences in bone mineral content and density at the fracture site between the vehicle and FGF-2 groups were seen at 6 weeks and thereafter. FGF-2 also increased the mechanical property of the fracture site. We conclude that FGF-2 accelerates fracture healing and prevents nonunion in primates, and therefore propose that it is a potent bone anabolic agent for clinical use.

This article has been cited by other articles:

				H. J. Seeherman, K. Azari, S. Bidic, L. Rogers, X. J. Li, J. O. Hollinger, and J. M. Wozney rhBMP-2 Delivered in a Calcium Phosphate Cement Accelerates Bridging of Critical-Sized Defects in Rabbit Radii J. Bone Joint Surg. Am., July 1, 2006; 88(7): 1553 - 1565. [Abstract] [Full Text] [PDF]

				A. H. R. W. Simpson, L. Mills, and B. Noble The role of growth factors and related agents in accelerating fracture healing J Bone Joint Surg Br, June 1, 2006; 88-B(6): 701 - 705. [Full Text] [PDF]

				M. Nakae, H. Kamiya, K. Naruse, N. Horio, Y. Ito, R. Mizubayashi, Y. Hamada, E. Nakashima, N. Akiyama, Y. Kobayashi, et al. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes, May 1, 2006; 55(5): 1470 - 1477. [Abstract] [Full Text] [PDF]

				H. J. Seeherman, M. Bouxsein, H. Kim, R. Li, X. J. Li, M. Aiolova, and J. M. Wozney Recombinant Human Bone Morphogenetic Protein-2 Delivered in an Injectable Calcium Phosphate Paste Accelerates Osteotomy-Site Healing in a Nonhuman Primate Model J. Bone Joint Surg. Am., September 1, 2004; 86(9): 1961 - 1972. [Abstract] [Full Text] [PDF]

				T. A. Einhorn, R. J Majeska, A. Mohaideen, E. M. Kagel, M. L. Bouxsein, T. J. Turek, and J. M. Wozney A Single Percutaneous Injection of Recombinant Human Bone Morphogenetic Protein-2 Accelerates Fracture Repair J. Bone Joint Surg. Am., August 1, 2003; 85(8): 1425 - 1435. [Abstract] [Full Text] [PDF]

				H. Seeherman, R. Li, and J. Wozney A Review of Preclinical Program Development for Evaluating Injectable Carriers for Osteogenic Factors J. Bone Joint Surg. Am., August 1, 2003; 85(90003): 96 - 108. [Full Text] [PDF]

				F. Liu, L. Malaval, and J. E. Aubin Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation J. Cell Sci., May 1, 2003; 116(9): 1787 - 1796. [Abstract] [Full Text] [PDF]

				T. Shimoaka, T. Ogasawara, A. Yonamine, D. Chikazu, H. Kawano, K. Nakamura, N. Itoh, and H. Kawaguchi Regulation of Osteoblast, Chondrocyte, and Osteoclast Functions by Fibroblast Growth Factor (FGF)-18 in Comparison with FGF-2 and FGF-10 J. Biol. Chem., February 22, 2002; 277(9): 7493 - 7500. [Abstract] [Full Text] [PDF]